Achilles Therapeutics (Achilles Therapeutics) Total Operating Expense : $75.26 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Achilles Therapeutics Total Operating Expense?

Achilles Therapeutics's Total Operating Expense for the three months ended in Dec. 2023 was $19.51 Mil. Achilles Therapeutics's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $75.26 Mil.

Achilles Therapeutics Total Operating Expense Historical Data

The historical data trend for Achilles Therapeutics's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achilles Therapeutics Total Operating Expense Chart

Achilles Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Operating Expense

13.78

33.73

64.20

78.38

75.26

Achilles Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Operating Expense	Get a 7-Day Free Trial												22.83	18.55	18.09	19.10	19.51

Achilles Therapeutics Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $75.26 Mil.

Achilles Therapeutics Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Achilles Therapeutics's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Achilles Therapeutics (Achilles Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achilles Therapeutics PLC (NAS:ACHL) » Definitions » Total Operating Expense

Comparable Companies

Traded in Other Exchanges

698:Germany

Address

245 Hammersmith Road, London, GBR, W6 8PW

Website

https://www.achillestx.com

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.